Bengaluru & Hyderabad, India; October 8, 2024: Aurigene Oncology Limited, a wholly-owned subsidiary of Dr. Reddy’s Laboratories Limited and a clinical stage biotech committed to bringing
Hyderabad India; October 2, 2024 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as
September 06, 2024 National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ) BSE Limited (Scrip Code: 500124) New York Stock Exchange Inc. (Stock Code: RDY)
• Malaria is a life-threatening public health issue, particularly in low- and middle-income countries. There is a need for an effective, affordable, and accessible preventive and/or
NACDS Total Store Expo 2024 August 17 – 19, 2024 | Boston, MA Discover new and innovative products, technology and services and find the partners
Hyderabad India; July 29, 2024 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to
Cardinal Health RBC 2024 July 24 – 27, 2024 | Chicago, IL Join the more than 4,000 independent pharmacy owners looking for new ways to
Aurigene will provide cell therapy discovery services to Edity to support the latter’s clinical development Hyderabad, India. July 01, 2024: Aurigene Pharmaceutical Services Limited (Aurigene),
• Portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol and Thrive in markets outside of the
McKesson ideaShare 2024 | June 23 – 26, 2024 | New Orleans, LA “McKesson ideaShare is the nation’s premier community pharmacy event that empowers current
